Publications


2023

A Clinical Risk Model for Personalized Screening and Prevention of Breast Cancer.

Eriksson M, Czene K, Vachon C, Conant EF, Hall P.


Cancers (Basel)
202306
https://pubmed.ncbi.nlm.nih.gov/37370856/

Novel predictions of invasive breast cancer risk in mammography screening cohorts.

Strandberg R, Czene K, Hall P, Humphreys K.


Epub
202306
https://pubmed.ncbi.nlm.nih.gov/37337390/

Studying the association between longitudinal mammographic density measurements and breast cancer risk: a joint modelling approach.

Illipse M, Czene K, Hall P, Humphreys K.


Breast Cancer Res
202306
https://pubmed.ncbi.nlm.nih.gov/37296473/

Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six-arm placebo-controlled trial in healthy women.

Gabrielson M, Hammarström M, Bäcklund M, Bergqvist J, Lång K, Rosendahl AH, Borgquist S, Hellgren R, Czene K, Hall P.


Int J Cancer
202306
https://pubmed.ncbi.nlm.nih.gov/36637153/

Prediction of breast cancer risk for sisters of women attending screening.

Mao X, He W, Eriksson M, Lindström LS, Holowko N, Bajalica-Lagercrantz S, Hammarström M, Grassmann F, Humphreys K, Easton D, Hall P, Czene K.


J Natl Cancer Inst
202305
https://pubmed.ncbi.nlm.nih.gov/37243694/

Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women

Hammarström M, Gabrielson M, Crippa A, Discacciati A, Eklund M, Lundholm C, Bäcklund M, Wengström Y, Borgquist S, Bergqvist J, Eriksson M, Tapia J, Czene K, Hall P.


BJC
202305
https://pubmed.ncbi.nlm.nih.gov/37149701/

Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer.

Eriksson M, Czene K, Vachon C, Conant EF, Hall P.


J Clin Oncol
202305
https://pubmed.ncbi.nlm.nih.gov/36930854/

Clinical biomarker-based biological aging and risk of cancer in the UK Biobank.

Mak JKL, McMurran CE, Kuja-Halkola R, Hall P, Czene K, Jylhävä J, Hägg S.


Epub
202304
https://pubmed.ncbi.nlm.nih.gov/37120669/

A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31.

Barnekow E, Hasslow J, Liu W, Bryant P, Thutkawkorapin J, Wendt C, Czene K, Hall P, Margolin S, Lindblom A.


Int J Mol Sci
202302
https://pubmed.ncbi.nlm.nih.gov/36901898/

Factors Associated With False-Positive Recalls in Mammography Screening.

Mao X, He W, Humphreys K, Eriksson M, Holowko N, Strand F, Hall P, Czene K.


J Natl Compr Canc Netw
202302
https://pubmed.ncbi.nlm.nih.gov/36791753/

Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Breast Cancer: Evidence from a General Female Population and a Mammographic Screening Cohort in Sweden

Kejia Hu, Maria Feychting, Donghao Lu, Arvid Sjölander, Kamila Czene, Per Hall, Fang Fang.


Cancers (Basel)
202301
https://pubmed.ncbi.nlm.nih.gov/36765650/

A Randomized Controlled Trial of Soy Isoflavone Intake on Mammographic Density among Malaysian Women.

Rajaram N, Yap B, Eriksson M, Mariapun S, Tan LM, Sa’at H, Ho ELM, Taib NAM, Khor GL, et al.


Nutrients
202301
https://pubmed.ncbi.nlm.nih.gov/36678170/

Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Breast Cancer: Evidence from a General Female Population and a Mammographic Screening Cohort in Sweden.

Hu K, Feychting M, Lu D, Sjölander A, Czene K, Hall P, Fang F.


Cancer (Basel)
202301
https://pubmed.ncbi.nlm.nih.gov/36765650/

2022

Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study.

Yang X, Eriksson M, Czene K, Lee A, Leslie G, Lush M, Wang J, Dennis J, Dorling L, Carvalho S, Mavaddat N, Simard J, Schmidt MK, Easton DF, Hall P, Antoniou AC.


J Med Genet
202212
https://pubmed.ncbi.nlm.nih.gov/36162852/

Postmenopausal overweight and breast cancer risk; results from the KARMA cohort.

Klintman M, Rosendahl AH, Randeris B, Eriksson M, Czene K, Hall P, Borgquist S.


Breast Cancer Res Treat
202211
https://pubmed.ncbi.nlm.nih.gov/36040641/

Topical Endoxifen for Mammographic Density Reduction-A Randomized Controlled Trial

Magnus Bäcklund, Mikael Eriksson, Marike Gabrielson, Mattias Hammarström, Steve Quay, Jenny Bergqvist, Roxanna Hellgren, Kamila Czene, Per Hall.


Oncologist
202207
https://pubmed.ncbi.nlm.nih.gov/35604960/

Risk Assessment in Population-Based Breast Cancer Screening.

Eriksson M, Conant EF, Kontos D, Hall P.


JCO
202207
https://pubmed.ncbi.nlm.nih.gov/35452252/

Time to Mammographic Density Decrease After Exposure to Tamoxifen

Magnus Bäcklund, Mikael Eriksson, Mattias Hammarström, Linda Thoren, Jenny Bergqvist, Sara Margolin, Roxanna Hellgren, Yvonne Wengström, Marike Gabrielson, Kamila Czene, Per Hall.


Oncologist
202207
https://pubmed.ncbi.nlm.nih.gov/35605013/

Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention.

Moorthie S, Babb de Villiers C, Burton H, Kroese M, Antoniou AC, Bhattacharjee P, Garcia-Closas M, Hall P, Schmidt MK.


Prev Med
202206
https://pubmed.ncbi.nlm.nih.gov/35526672/

A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care.

Eriksson M, Destounis S, Czene K, Zeiberg A, Day R, Conant EF, Schilling K, Hall P.


Sci Transl Med
202205
https://pubmed.ncbi.nlm.nih.gov/35544593/